Search Results - "Cappelletto, Paola Cristina"

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL) by Cafaro, Alessandro, Foca, Flavia, Nanni, Oriana, Chiumente, Marco, Coppola, Marina, Baldo, Paolo, Orzetti, Sabrina, Enrico, Fiorenza, Ladisa, Vito, Lerose, Rosa, Nardulli, Patrizia, Maiolino, Piera, Gradellini, Federica, Gasbarro, Anna Rita, Carrucciu, Gisella, Provasi, Riccardo, Cappelletto, Paola Cristina, Pasqualini, Alessandra, Vecchia, Stefano, Veraldi, Marianna, De Francesco, Adele Emanuela, Crinò, Lucio, Delmonte, Angelo, Masini, Carla

“…The phase III Keynote-189 trial established a first-line treatment combining pembrolizumab with pemetrexed and platinum as a standard treatment for patients…”
Get full text

Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib by Mian, Michael, Pescosta, Norbert, Badiali, Stefania, Cappelletto, Paola Cristina, Marcheselli, Luigi, Luminari, Stefano, Patriarca, Francesca, Zambello, Renato, Pascarella, Anna, Tagariello, Giuseppe, Marabese, Alessandra, Mondello, Patrizia, Billio, Atto, Cortelazzo, Sergio

Get full text

Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (" PEMBROREAL " Study) by Cafaro, Alessandro, Foca, Flavia, Nanni, Oriana, Chiumente, Marco, Coppola, Marina, Russi, Alberto, Svegliati, Elena, Baldo, Paolo, Orzetti, Sabrina, Enrico, Fiorenza, Foglio, Federico, Pinnavaia, Davide, Ladisa, Vito, Lauria Pantano, Claudia, Lerose, Rosa, Nardulli, Patrizia, Ferraiuolo, Simona, Maiolino, Piera, De Stasio, Immacolata, Gradellini, Federica, Gasbarro, Anna Rita, Santeramo, Rossella, Carrucciu, Gisella, Provasi, Riccardo, Cirino, Mario, Cappelletto, Paola Cristina, Fonzi, Elisabetta, Pasqualini, Alessandra, Vecchia, Stefano, Veraldi, Marianna, De Francesco, Adele Emanuela, Crinò, Lucio, Delmonte, Angelo, Masini, Carla

“…Results from the phase III clinical trial established pembrolizumab monotherapy as the first-line standard of care for patients with metastatic NSCLC who have…”
Get full text